Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Masimo to Present in the Wells Fargo Healthcare Conference
09:00am, Thursday, 28'th Aug 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time
Here is Why Growth Investors Should Buy Masimo (MASI) Now
01:46pm, Monday, 25'th Aug 2025
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
10:45am, Monday, 25'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Masimo sues US Customs over approval of Apple Watch imports
06:52pm, Wednesday, 20'th Aug 2025
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading tec
Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring
02:26pm, Wednesday, 20'th Aug 2025
MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.
Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters
08:00am, Tuesday, 19'th Aug 2025
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.
3 Reasons Why Growth Investors Shouldn't Overlook Masimo (MASI)
01:46pm, Thursday, 07'th Aug 2025
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand
01:50pm, Wednesday, 06'th Aug 2025
Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.
Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript
11:03pm, Tuesday, 05'th Aug 2025
Masimo Corporation (NASDAQ:MASI ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Catherine M. Szyman - CEO & Director Eli Kammerman - Vice President of Business Develo
Masimo (MASI) Beats Q2 Earnings and Revenue Estimates
07:51pm, Tuesday, 05'th Aug 2025
Masimo (MASI) came out with quarterly earnings of $1.33 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.86 per share a year ago.
Masimo Reports Second Quarter 2025 Results
04:05pm, Tuesday, 05'th Aug 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 28, 2025. Second Quarter 2025 Results From Continuing Operati
Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5
09:00am, Tuesday, 22'nd Jul 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2025 financial results for the period ended June 28, 2025, after the market closes on Tuesday, August 5, 2025. The co
Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation
08:00am, Tuesday, 08'th Jul 2025
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo has joined the American Heart Association's Innovators' Network, a health care technology consortium.
SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Leading shareholder rights law firm Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duties by current and former direc
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers
